EXACT Sciences (EXAS) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30063P1057

Exact Sciences Corporation is a company that offers cancer screening and diagnostic test products globally, in addition to the United States. The company's flagship product, Cologuard, is a stool-based DNA screening test used to detect biomarkers linked to colorectal cancer and pre-cancer. Furthermore, Exact Sciences provides various other tests such as the Oncotype DX Breast and Colon Recurrence Score Tests, as well as the OncoExTra Test for tumor profiling in patients with advanced cancer.

Moreover, Exact Sciences Corporation also provides Covid-19 testing services. The company is continuously working on improving the performance of the Cologuard test and developing new tests based on blood and other bodily fluids. Additionally, Exact Sciences holds license agreements with MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, the company is headquartered in Madison, Wisconsin.

For more information, visit their website: https://www.exactsciences.com.

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for EXACT Sciences (EXAS) - Stock Price & Dividends

EXAS Stock Overview

Market Cap in USD 11,446m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Biotechnology
TER 0.00%
IPO / Inception 2001-02-01

EXAS Stock Ratings

Fundamental -2.50
Dividend -
Growth 5y -2.95
Rel. Performance vs Sector -2.45
Analysts 4.61
Fair Price Total Ret. 50.21
Fair Price DCF -

EXAS Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

EXAS Growth Ratios

Growth 12m -8.71%
Growth Correlation 12m -22%
Growth Correlation 3m -43%
CAGR 5y -9.21%
CAGR / Mean Drawdown -0.24
Sharpe Ratio 12m -0.32
Alpha vs SP500 12m -48.49
Beta vs SP500 5y weekly 1.40
CAPM 9.12%
Average Daily Range 2m 3.79%
Regime Oscillator 13.69
Volatility GJR Garch 1y 50.22%
Price / SMA 50 -13.77%
Price / SMA 200 -24.34%
Current Volume 3123.9k
Average Volume 20d 2379.7k

External Links for EXAS Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of EXAS stocks?
As of February 28, 2024, the stock is trading at USD 56.90 with a total of 3,123,918 shares traded.
Over the past week, the price has changed by -9.31%, over one month by -11.48%, over three months by -13.55% and over the past year by -5.50%.
Why is EXAS stock down?
Check with which Index or Commodity EXAS has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return EXAS Return S&P 500
1 Month -11.48% 4.00%
3 Months -13.55% 11.99%
12 Months -5.50% 29.39%
What is the forecast for EXAS stock price target?
According to ValueRays Forecast Model, EXAS EXACT Sciences will be worth about 55.3 in February 2025. The stock is currently trading at 56.90. This means that the stock has a potential downside of -2.9%.
Issuer Forecast Upside
Wallstreet Target Price 91.6 60.9%
Analysts Target Price 106.4 87.0%
ValueRay Target Price 55.3 -2.9%